Author: Spanakis, Nikolaos; Tsiodras, Sotirios; Haagmans, Bart L.; Raj, V. Stalin; Pontikis, Kostantinos; Koutsoukou, Antonia; Koulouris, Nikolaos G.; Osterhaus, Albert D.M.E.; Koopmans, Marion P.G.; Tsakris, Athanassios
Title: Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen Cord-id: o8m6xdra Document date: 2014_9_18
ID: o8m6xdra
Snippet: Serological, molecular and phylogenetic analyses of a recently imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) in Greece are reported. Although MERS-CoV remained detectable in the respiratory tract secretions of the patient until the fourth week of illness, viraemia was last detected 2 days after initiation of triple combination therapy with pegylated interferon, ribavirin and lopinavir/ritonavir, administered from Day 13 of illness. Phylogenetic analysis of the virus sh
Document: Serological, molecular and phylogenetic analyses of a recently imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) in Greece are reported. Although MERS-CoV remained detectable in the respiratory tract secretions of the patient until the fourth week of illness, viraemia was last detected 2 days after initiation of triple combination therapy with pegylated interferon, ribavirin and lopinavir/ritonavir, administered from Day 13 of illness. Phylogenetic analysis of the virus showed close similarity with other human MERS-CoVs from the recent Jeddah outbreak in Saudi Arabia. Immunoglobulin G (IgG) titres peaked 3 weeks after the onset of illness, whilst IgM levels remained constantly elevated during the follow-up period (second to fifth week of illness). Serological testing confirmed by virus neutralisation assay detected an additional case that was a close contact of the patient.
Search related documents:
Co phrase search for related documents- acute ards respiratory disease syndrome and low oxygen saturation: 1
- acute kidney injury and liver toxicity: 1
- acute kidney injury and loading dose: 1
- acute kidney injury and local hospital: 1
- acute kidney injury and lopinavir interferon: 1
- acute kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute kidney injury and low oxygen saturation: 1
- acute respiratory syndrome and additional contact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory syndrome and liver toxicity: 1, 2, 3, 4
- acute respiratory syndrome and loading dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory syndrome and local hospital: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lopinavir interferon: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and low oxygen saturation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- additional contact and lopinavir ritonavir: 1
- liver toxicity and lopinavir interferon: 1
- liver toxicity and lopinavir ritonavir: 1, 2
- loading dose and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7
- local hospital and lopinavir ritonavir: 1, 2
Co phrase search for related documents, hyperlinks ordered by date